Understanding Why Albemarle Stock Is Moving Up Today.

By Naomi Wentworth • Tuesday, August 29 12:18 • Permanent Link

Albemarle stock is trading -25.36% below its average target price of $263.32 after marking a 3.6% during today's afternoon session. Analysts are giving the large-cap Chemicals company an average rating of buy and target prices ranging from $155.0 to $344.0 per share.

Albemarle has an average level of shares sold short, at 6.3% of its total share float. The stock's short ratio (also called days to cover) is 3.2. The company's insiders own 0.23% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.

Institutional investors own 89.7% of Albemarle's shares, which indicates they have a high level of confidence in the company.

Institutions Invested in Albemarle

Date Reported	Holder	Percentage	Shares	Value
2023-06-30	Vanguard Group Inc	12%	14,039,343	$2,759,292,378
2023-06-30	Blackrock Inc.	9%	10,157,015	$1,996,259,659
2023-06-30	State Street Corporation	4%	5,242,800	$1,030,419,876
2023-06-30	Bank of America Corporation	4%	5,117,596	$1,005,812,283
2023-06-30	Capital Research Global Investors	3%	3,381,656	$664,630,647
2023-06-30	Franklin Resources, Inc.	3%	3,135,732	$616,296,746
2023-06-30	Baillie Gifford and Company	2%	2,494,230	$490,215,947
2023-06-30	Geode Capital Management, LLC	2%	2,481,901	$487,792,805
2023-06-30	Capital International Investors	2%	2,267,914	$445,735,802
2023-06-30	Primecap Management Company	2%	2,099,025	$412,542,359

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.